Medicine, the last station for demonetised notes?
After three weeks of demonetisation move, the chemists and pharmacy chains are witnessing a growth in sales of chronic medicines. According to a data provided by a consultancy firm AWACS, there is a huge impact on drug sales due to demonetisation. They found that chronic therapy drugs, which includes anti-diabetic, cardiovascular and blood pressure drugs have shown a significant increase in sales as compared to corresponding period of October.
The trend shows that since November 1, the sales of drugs for chronic therapy spike from Rs 14.1crore to Rs 16.8 crore.
“This clearly shows some chronic patients have used old notes to store their medicines for 2-3 months. Overall chronic therapy drugs may gain 10-15 per cent by this additional sales in November,” said Ameesh Masurekar, Director of AWACS.